Evidence map›Paper›PMID 41459592›Full record

ArticlePsychological medicine2025

Elevated psychiatric and substance use disorders in people with intellectual disabilities in a Swedish National Sample.

Ruth C Brown, Linda Abrahamsson, Jan Sundquist, Kristina Sundquist, Kenneth Kendler

Abstract read
In one paragraph

Article in Psychological medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruth C BrownDepartment of Psychiatry, https://ror.org/02nkdxk79Virginia Commonwealth University, USA.ORCID https://orcid.org/0000-0001-8614-1645
Linda AbrahamssonCenter for Primary Health Care Research, https://ror.org/012a77v79Lund University, Sweden.ORCID https://orcid.org/0000-0002-1372-5508
Jan SundquistCenter for Primary Health Care Research, https://ror.org/012a77v79Lund University, Sweden.ORCID https://orcid.org/0000-0001-7228-5015
Kristina SundquistCenter for Primary Health Care Research, https://ror.org/012a77v79Lund University, Sweden.ORCID https://orcid.org/0000-0001-8031-279X
Kenneth KendlerDepartment of Psychiatry, https://ror.org/02nkdxk79Virginia Commonwealth University, USA.

Funding

Genetic, Social, and Developmental Epidemiology of Drug Use DisordersR01DA030005 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI KENNETH SEEDMAN KENDLER, JAN O SUNDQUIST · 2010 to 2026
$7.6M
Social, Developmental and Genetic Epidemiology of Alcohol Use DisordersR01AA023534 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI KENDLER, KENNETH SEEDMAN, SUNDQUIST, KRISTINA · 2015 to 2023
$4.0M
NIAAA NIH HHS R01 AA023534NIAAA NIH HHS R01AA023534NIDA NIH HHS R01 DA030005NIDA NIH HHS R01DA030005Vetenskapsrådet 2020-01175Vetenskapsrådet 2021-06467
6 · The paper itself

Abstract

backgroundAdults with intellectual disability (ID) experience marked mental health inequities, yet population-wide estimates that capture both primary- and specialist-care diagnoses remain scarce.

methodsUsing nationwide Swedish registries, including primary care, specialist, inpatient, prescription drug, criminal, and suspicion registers, we included all individuals born in Sweden between 1958 and 1997 (N = 3,970,600), including 38,818 individuals with ID diagnoses (0.98%; 49.1% mild, 13.3% moderate, and 9.6% severe/profound). Hazard ratios (HR) were calculated using Cox proportional hazards regression to estimate the relative risk of lifetime diagnoses of major depression, anxiety disorders (ANX), obsessive-compulsive disorder (OCD), bipolar disorder (BD), attention-deficit/hyperactivity disorder (ADHD), drug use disorder, alcohol use disorder, schizophrenia, and other nonaffective psychosis. Additionally, cohort effects on psychiatric diagnosis risks in adults with intellectual disabilities versus the general population were evaluated.

resultsPeople with ID were at higher risk for all psychiatric and substance use disorders, with HRs ranging from 1.7-2.0 for major depression and anxiety, drug and alcohol use disorders, 3.5-5.8 for BD, OCD and ADHD, and 10.9-12.7 for schizophrenia and other nonaffective psychosis. Higher prevalence was consistently seen among those with mild versus moderate or severe/profound intellectual disability. Relative risks narrowed modestly in successive birth cohorts, although absolute differences remained substantial.

conclusionsAcross six decades of follow-up, adults with ID faced markedly higher psychiatric and substance-use morbidity - most pronounced for psychotic disorders - than the general population. Whole-system mental-health screening and tailored interventions are required to address this persistent disparity.

Indexed as

Intellectual DisabilityMental DisordersRegistriesSubstance-Related DisordersAdolescentAdultAgedComorbidityFemaleHumansMaleMiddle AgedSwedenYoung Adultepidemiologyhealth disparitiesintellectual disabilitypopulation studypsychiatric disordersregistry datasubstance use disorders

Identifiers

PMID41459592
PMCPMC12848947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.